Omadacycline Completed Phase 3 Trials for Skin Structures and Soft Tissue Infections / Bacterial Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02378480Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
NCT02877927Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI